Page 26 - Read Online
P. 26

control subjects, were investigated and their associations   present studies are needed to make an exact estimation of
            were assessed with prognostic factors.  The present   the results of current studies.
            case control study was done to determine possible
            relationships between  AA,  AG and GG polymorphisms   References
            of CTLA-4 gene and breast cancer-related factors. Results   1.   Boring  CC,  Squires TS, Tong T,  Montgomery  S.  Cancer
            revealed that the frequency of AA and GG genotypes in   statistic, 2004. CA Cancer J Clin 1994;44:7-26.
            breast cancer patients is higher than in controls, while   2.   Lippman ME, Lichter  AS, Danforth DN Jr. Diagnosis and
            AG genotype is more frequent in healthy controls.     Management of Breast Cancer. Philadelphia:  WB Saunders
            These results confi rm  the  fi ndings of two other studies   Co.; 1988.
            in Iran  and China,  which found GG genotype is   3.   Henderson IC, Canellos GP. Cancer of the breast: the past
                              [32]
                  [23]
                                                                  decade (fi rst of two parts). N Engl J Med 1980;302:17-30.
            more frequent in breast cancer patients. However, Erfani   4.   Bakhtiari  A,  Haj-Ahmadi  M.  Five-year  assessment  of  b      reast
            et  al.  did not  fi nd any difference between their study   cancer at Rajaee Hospital, Baboolsar (1991-1996).  Iran  J
                [24]
            groups in terms of AG genotype. Another study in China   Obstets Gynecol Infertil 2006;9:47-52.
            suggested that AG genotype is more prevalent in breast   5.   Li F, Sturgis EM, Chen X, Zafereo ME,  Wei Q, Li G.
                                                 [15]
            cancer patients.  Furthermore, Sun  et  al.  reported   Association of p53 codon 72 polymorphism with risk of
                         [33]
            that T cells with AA genotype are less active than those   second primary malignancy i  n patients with squamous cell
            with GG genotype, and AG is related to different cancer   carcinoma of the head and neck. Cancer 2010;116:2350-9.
            incidence in humans.                              6.   Wang G,  Yu D,  Tan  W, Zhao D,  Wu C, Lin D. Genetic
                                                                  polymorp   hism in chemokine CCL22 and susceptibility to
            The results of our study did not fi nd any relation between   Helicobacter  pylori infection-related gastric carcinoma.
            AA, AG and GG genotypes with respect to tumor stage,   Cancer 2009;115:2430-7.
            grade, receptors or lymph node involvement.  These   7.   Kristensen  VN, Børresen-Dale  AL. SNPs associated with
                                                                  molecular subtypes of breast cancer: On the usefulness of
            results are in agreement with results of  Wang  et  al.,    stratifi ed Genome-wide  Association Studies (GWAS) in
                                                         [16]
            who found no signifi cant relationship between  AG     the identifi cation of novel susceptibility loci.  Mol Oncol
            genotype and tumor size and lymph node involvement.   2008;2:12-5.
            Erfani et al.  found a relationship between AA genotype   8.   Kraft P, Haiman CA. GWAS identifi es a common breast cancer
                     [24]
            and lower lymph node involvemen  t and higher ER      risk allele among BRCA1 carriers. Nat Genet 2010;42:819-20.
            expression, but Ghaderi et al.  found that AA genotype   9.   Dranoff G. CTLA-4 blockade: unveiling immune regulation.
                                    [23]
                                                                  J Clin Oncol 2005;23:662-4.
            is related to higher rates of lymph node involvement and   10.  Hurwitz AA, Kwon ED, van Elsas A. Costimulatory wars: the
            tumor size; these fi ndings are different from our fi ndings.   tumor menace. Curr Opin Immunol 2000;12:589-96.
            Bi et al.  in his study reported that CTLA-4 expression   11.  Chen L. Co-inhibitory molecules of the B7-CD28 family in the
                   [34]
            is higher in stage 2 than stage 3 patients. There are also   control of T-cell immunity. Nat Rev Immunol 2004;4:336-47.
            some other studies, which revealed that  CTLA-4 gene   12.  Leach DR, Krummel MF,  Allison JP. Enhancement
            polymorphisms are related to higher stages and lymph   of antitumor immunity by CTLA-4 blockade.  Science
            node metastasis, [6,32]  which is not consistent with our   1996;271:1734-6.
            study. According to age, in our study and also in the Bi   13.  Hurwitz  AA, Foster BA, Kwon ED,  Truong  T, Choi EM,
                [34]
            et al.,  there was no relationship between CTLA-4 gene   Greenberg NM, Burg MB,  Allison JP. Combination
                                                                  immunotherapy of primary prostate cancer in a transgenic
            polymorphisms and age.                                mouse model using CTLA-4 blockade.  Cancer Res
                                                                  2000;60:2444-8.
            Li et al.  found a relationship between all CTLA-4 gene
                  [32]
            polymorphisms with estrogen and progesterone receptors.   14.  Ligers A,  Teleshova N, Masterman  T, Huang  WX, Hillert J.
                                                                  CTLA-4 gene expression is infl uenced by promoter and exon
            Also, Erfani et al.  detected a relationship between AG   1 polymorphisms. Genes Immun 2001;2:145-52.
                           [24]
            genotype and ER expression, which was not consistent   15.  Sun T, Zhou Y, Yang M, Hu Z, Tan W, Han X, Shi Y, Yao J,
            with our fi ndings.                                    Guo  Y,  Yu D,  Tian  T, Zhou X, Shen H, Lin D. Functional
                                                                  genetic variations in cytotoxic  T-lymphocyte antigen 4
            One of the limitations of our study is the failure to   and susceptibility to multiple types of cancer.  Cancer Res
            take into account risk factors such as age at menarche,   2008;68:7025-34.
            menopausal status, and environmental factors. It   16.  Wang L, Li D, Fu Z, Li H, Jiang  W, Li D.  Association of
            is imp  ortant to investigate the interaction between   CTLA-4 gene polymorphisms with sporadic breast cancer in
            single-nucleotide polymorphisms and these factors on the   Chinese Han population. BMC Cancer 2007;7:173.
            risk of breast cancer in a larger sample size in further   17.  Kouki  T, Sawai  Y, Gardine CA, Fisfalen ME,  Alegre ML,
            studies.                                              DeGroot LJ. CTLA-4 gene polymorphism at position 49
                                                                  in exon 1 reduces the inhibitory function of CTLA-4 and
            Based on our study, there is a relationship between   contributes to the pathogenesis of Graves’ disease. J Immunol
            CTLA-4 gene 1661AG polymorphisms and incidence of     2000;165:6606-11.
            breast cancer, but these polymorphisms are not effective   18.  Mäurer M, Loserth S, Kolb-Mäurer  A, Ponath  A,  Wiese S,
                                                                  Kruse N, Rieckmann P.  A polymorphism in the human
            for prognosis. Considering the controversial reports on   cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49)
            this issue, more studies are needed with larger sample   alters T-cell activation. Immunogenetics 2002;54:1-8.
            size. Also, a critical review and possible meta-analysis of   19.  Ueda H, Howson JM, Esposito L, Heward J, Snook H,

                Journal of Cancer Metastasis and Treatment  ¦  Volume 1 ¦ Issue 1 ¦ April 15, 2015 ¦       19
   21   22   23   24   25   26   27   28   29   30   31